MECP2 and psychiatric disorder: Thus, astrocytes differentiated from RTT patient-derived, mutant MECP2-expressing hiPSC lines may be useful for drug development for RTT therapy, because some drugs for mental disorders (e.g., antidepressants) affect not only neurons, but also activate astrocytes.